The winners of the CPHI Pharma Awards 2026 include a neurodegeneration platform, a track-and-trace packaging innovation, a ...

Shadow AI and vendor data retention put GMP records and trade secrets at risk. AI Pulse Check panelists outline what pharma ...

"What matters is that someone owns the entire pathway for that product from identifying the unmet need through development, ...

In US regulatory news, the FDA opened applications for its Expedited IND Pilot on September 15. 1 The program pairs drug ...

Manufacturers are encouraged to treat resiliency policy as an actionable trend and proactively shape solutions rather than ...

Nitrosamine have been a problem in pharmaceutical manufacturing since approximately 2018, after the carcinogenicimpurities were found in statin drugs. Since then, regulators and pharmaceutical ...

The deal also gives Novartis exclusive options to license additional next-generation programs built on Abogen's proprietary ...

This week on PharmTech, Merck diversified its pipeline, USP emphasizes supply chain security, AI systems are examined, and speakers preview their presentations at CPHI Milan and AAPS PharmSci 360.

Scarboro contends these findings should be treated as design information rather than as a sign that patients need more ...

Access Part 1 of this interview, in which Piervincenzi explains how benchmarking could reward reliable generic drug suppliers ...

Capsugel's Bram Baert and Sandrine Picco argue that chasing zero nitrite in pharmaceutical excipients is often impractical ...

Capsugel's Bram Baert and Sandrine Picco argue that chasing zero nitrite in pharmaceutical excipients is often impractical ...